XML 37 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Note 2 - Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Notes Tables  
Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]
   

March 31,

   

December 31,

 
   

2026

   

2025

 

Cash and cash equivalents

  $ 18,405     $ 7,958  

Restricted cash included in other assets

    435       267  

Total cash, cash equivalents, and restricted cash in the unaudited condensed consolidated statements of cash flows

  $ 18,840     $ 8,225  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   

Three Months Ended March 31,

 
   

2026

   

2025*

 

Numerator for basic and diluted income (loss) per share:

               

Net income (loss) from continuing operations attributable to common stockholders

  $ 552,403     $ (3,330 )

Net income from discontinued operations

          11,000  

Net income

  $ 552,403     $ 7,670  
                 

Denominator for income (loss) per share:

               

Weighted average shares outstanding – basic (diluted for net loss)

    26,015       1,062  
Effect of dilutive January 2026 Pre-Funded Warrants     139,616        

Effect of dilutive in-the-money warrants and RSUs

    78       21  

Weighted average shares outstanding – diluted for net income

    165,709       1,083  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   

As of March 31,

 
   

2026

   

2025*

 

Common stock equivalent of Series B Non-Voting Convertible Preferred Stock (the “Series B Preferred Stock”)

          3  
October 2025 Pre-funded Warrants     22,664        

Stock options

          1  

Stock warrants

    4       951  
      22,668       955